imipenem + cilastatin sodium 500mg + 500mg powder for injection im/iv
viridis enterprises - imipenem , cilastatin sodium - powder for injection im/iv - 500mg + 500mg
imipenem and cilastatin- imipenem and cilastatin sodium injection, powder, for solution imipenem and cilastatin- imipenem and c
fresenius kabi usa, llc - imipenem (unii: 71otz9ze0a) (imipenem anhydrous - unii:q20im7he75), cilastatin sodium (unii: 5428wxz74m) (cilastatin - unii:141a6amn38) - imipenem and cilastatin for injection, usp (i.v.) for intravenous use is indicated for the treatment of lower respiratory tract infections caused by susceptible strains of staphylococcus aureus (penicillinase-producing isolates), acinetobacter species, enterobacter species, escherichia coli , haemophilus influenzae , haemophilus parainfluenzae , klebsiella species, serratia marcescens . imipenem and cilastatin for injection, usp (i.v.) is indicated for the treatment of urinary tract infections (complicated and uncomplicated) caused by susceptible strains of enterococcus faecalis , staphylococcus aureus (penicillinase-producing isolates), enterobacter species, escherichia coli , klebsiella species, morganella morganii , proteus vulgaris , providencia rettgeri ,
imipenem and cilastatin- imipenem and cilastatin sodium injection, powder, for solution
fresenius kabi usa, llc - imipenem (unii: 71otz9ze0a) (imipenem anhydrous - unii:q20im7he75), cilastatin sodium (unii: 5428wxz74m) (cilastatin - unii:141a6amn38) - imipenem and cilastatin for injection, usp (i.v.) for intravenous use is indicated for the treatment of lower respiratory tract infections caused by susceptible strains of staphylococcus aureus (penicillinase-producing isolates), acinetobacter species, enterobacter species, escherichia coli , haemophilus influenzae , haemophilus parainfluenzae , klebsiella species, serratia marcescens . imipenem and cilastatin for injection, usp (i.v.) is indicated for the treatment of urinary tract infections (complicated and uncomplicated) caused by susceptible strains of enterococcus faecalis , staphylococcus aureus (penicillinase-producing isolates), enterobacter species, escherichia coli , klebsiella species, morganella morganii , proteus vulgaris , providencia rettgeri ,
imipenem and cilastatin injection, powder, for solution
wg critical care, llc - imipenem anhydrous (unii: q20im7he75) (imipenem anhydrous - unii:q20im7he75), cilastatin sodium (unii: 5428wxz74m) (cilastatin - unii:141a6amn38) - imipenem and cilastatin for injection, usp for intravenous use is indicated for the treatment of lower respiratory tract infections caused by susceptible strains of staphylococcus aureus (penicillinase-producing isolates), acinetobacter species, enterobacter species, escherichia coli , haemophilus influenzae , haemophilus parainfluenzae , klebsiella species, serratia marcescens. imipenem and cilastatin for injection, usp is indicated for the treatment of urinary tract infections (complicated and uncomplicated) caused by susceptible strains of enterococcus faecalis , staphylococcus aureus (penicillinase-producing isolates), enterobacter species, escherichia coli , klebsiella species, morganella morganii , proteus vulgaris , providencia rettgeri , pseudomonas aeruginosa. imipenem and cilastatin for injection, usp is indicated for the treatment of intra-abdominal infections caused by susceptible strains of enterococcus faecalis , staphylococcus aureus (penicillinase-producing isolates), staphylococcus ep
imipenem/cilastatin 500 mg/500 mg powder for solution for infusion
fresenius kabi deutschland gmbh - imipenem; cilastatin - powder for solution for infusion - 500 mg/500 milligram(s) - imipenem and enzyme inhibitor
imipenem/cilastatin 500mg/500mg powder for solution for infusion
hospira uk limited - cilastatin; imipenem - powder for solution for infusion - cilastatin 500 mg; imipenem 500 mg - antibacterials for systemic use
imipenem/cilastatin hospira pdr for soln for infusion 500mg/500mg
pfizer hellas s.a. 243 messoghion ave., neo psychiko 15451, athens, greece - cilastatin, imipenem - powder for solution for infusion - cilastatin 500 mg imipenem 500 mg - antibacterials for systemic use
imipenem/cilastatin aptapharma 500 mg/500 mg powder for solution for infusion
apta medica internacional d.o.o likozarjeva ulica 6, 1000 ljubljana, , slovenia - imipenem, cilastatin - powder for solution for infusion - imipenem 500 mg cilastatin 500 mg - antibacterials for systemic use
imipenem/cilastatine fresenius kabi 500 mg - 500 mg inf. sol. (pwdr.) i.v. vial
fresenius kabi sa-nv - cilastatin sodium 530 mg - eq. cilastatin 500 mg; imipenem monohydrate 530 mg - eq. imipenem 500 mg - powder for solution for infusion - 500 mg - 500 mg - cilastatin sodium; imipenem monohydrate 530 mg - imipenem and enzyme inhibitor
imipenem cilastatin kabi 500 mg 500 mg powder for solution for infusion
fresenius kabi malaysia sdn. bhd - cilastatin sodium; imipenem monohydrate -